The relationship of coffee consumption and CVD risk factors in elderly patients with T2DM
Tóm tắt
Clinical studies suggest increasing prevalence of cardiovascular disease (CVD) risk factors and diabetes among the elderly. Meanwhile, some food compounds, such as coffee, can also have beneficial effects on CVD risk factors. The aim of the present study was to examine the relationship between coffee consumption and CVD risk factors in the elderly with type 2 diabetes mellitus (T2DM). This cross-sectional study was performed during 2017 on 300 elderly people above 60 years of age with T2DM in Isfahan, Iran. Dietary assessment was performed using a food frequency questionnaire. Coffee consumption was classified into three groups including < 1, 1–3, and > 3 cups/day. Partial correlation test was used to investigate the relationship between CVD risk factors and usual coffee consumption. The mean age and body mass index of participants were 70.04 ± 4.87 years and 24.74 ± 3.34 kg/m2 respectively. Coffee consumption had a significant inverse relationship with fasting plasma glucose (FPG) and diastolic blood pressure (DBP) in the elderly with T2DM (r: − 0.117, 0.134; p: 0.046, 0.022). Triglyceride (TG) and high-density lipoprotein cholesterol (HDL-C) had a significant positive relationship with coffee consumption levels (r: 0.636, 0.128; p: 0.028, 0.029). These results were obtained after controlling for potential confounders. Increasing coffee consumption was linked to improved status of some CVD risk factors including FPG, HDL-C, and DBP in the elderly with T2DM. Nevertheless, increasing coffee consumption was also associated with higher TG level and had no significant effect on other risk factors. Further studies are required to confirm these results.
Tài liệu tham khảo
Darooghegi Mofrad M, Namazi N, Larijani B, Surkan PJ, Azadbakht L. Association of the Elderly Dietary Index with cardiovascular disease risk factors in elderly men: a cross-sectional study. Nutr Diet. 2019;76(5):580–8.
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Executive summary: heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131(4):434–41.
Talaei M, Sarrafzadegan N, Sadeghi M, Oveisgharan S, Marshall T, Thomas GN, et al. Incidence of cardiovascular diseases in an Iranian population: the Isfahan Cohort Study. Arch. Iran. Med. 2013;16(3).
Mehta S, Dhawan V. Lifestyle-Related Health Behaviors Associated with Cardiovascular Health in Adolescents: A Stairway to Healthy Future. EC Cardiol. 2020;7:40–4.
Mertens E, Markey O, Geleijnse JM, Lovegrove JA, Givens DI. Adherence to a healthy diet in relation to cardiovascular incidence and risk markers: evidence from the Caerphilly Prospective Study. Eur J Nutr. 2018;57(3):1245–58.
Miranda AM, Steluti J, Fisberg RM, Marchioni DM. Association between coffee consumption and its polyphenols with cardiovascular risk factors: A population-based study. Nutrients. 2017;9(3):276.
Torres-Collado L, Garcia-de-la-Hera M, Navarrete-Muñoz E, Notario-Barandiaran L, Gonzalez-Palacios S, Zurriaga O, et al. Coffee consumption and mortality from all causes of death, cardiovascular disease and cancer in an elderly Spanish population. Eur J Nutr. 2019;58(6):2439–48.
de Melo Pereira GV, de Carvalho Neto DP, Júnior AIM, do Prado FG, Pagnoncelli MGB, Karp SG, et al. Chemical composition and health properties of coffee and coffee by-products. Advances in Food and Nutrition Research. 91: Elsevier; 2020. p. 65–96.
Grosso G, Godos J, Galvano F, Giovannucci EL. Coffee, caffeine, and health outcomes: an umbrella review. Annu Rev Nutr. 2017;37:131–56.
Torres-Collado L, García-de la Hera M, Navarrete-Muñoz EM, Compañ-Gabucio LM, Gonzalez-Palacios S, Vioque J. Coffee drinking and associated factors in an elderly population in Spain. Int J Environ Res Public Health. 2018;15(8):1661.
Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose–response meta-analysis of prospective cohort studies. Circulation. 2014;129(6):643–59.
Tverdal A, Selmer R, Cohen JM, Thelle DS. Coffee consumption and mortality from cardiovascular diseases and total mortality: Does the brewing method matter? Eur J Prev Cardiol. 2020;27(18):1986–93.
Sado J, Kitamura T, Kitamura Y, Liu R, Ando E, Sobue T, et al. Coffee consumption and all-cause and cardiovascular mortality-three-prefecture Cohort in Japan-. Circ J. 2019;83(4):757–66.
Nordestgaard AT, Nordestgaard BG. Coffee intake, cardiovascular disease and all-cause mortality: observational and Mendelian randomization analyses in 95 000–223 000 individuals. Int J Epidemiol. 2016;45(6):1938–52.
Pimpley V, Patil S, Srinivasan K, Desai N, Murthy PS. The chemistry of chlorogenic acid from green coffee and its role in attenuation of obesity and diabetes. Preparative Biochem Biotechnol. 2020;50:1–10.
Shin S, Lim J, Lee H-W, Kim CE, Kim S-A, Lee J-K, et al. Association between the prevalence of metabolic syndrome and coffee consumption among Korean adults: results from the Health Examinees study. Appl Physiol Nutr Metab. 2019;44(12):1371–8.
Voskoboinik A, Koh Y, Kistler PM. Cardiovascular effects of caffeinated beverages. Trends Cardiovasc Med. 2019;29(6):345–50.
Bjørngaard JH, Nordestgaard AT, Taylor AE, Treur JL, Gabrielsen ME, Munafò MR, et al. Heavier smoking increases coffee consumption: findings from a Mendelian randomization analysis. Int J Epidemiol. 2017;46(6):1958–67.
Lieberman HR, Stavinoha T, McGraw S, White A, Hadden L, Marriott BP. Caffeine use among active duty US Army soldiers. J Acad Nutr Dietetics. 2012;112(6):902–12.
Grosso G, Stepaniak U, Micek A, Stefler D, Bobak M, Pajak A. Coffee consumption and mortality in three Eastern European countries: results from the HAPIEE (Health, Alcohol and Psychosocial factors In Eastern Europe) study. Public Health Nutr. 2017;20(1):82–91.
Mehri N, Messkoub M, Kunkel S. Trends, determinants and the implications of population aging in Iran. Ageing Int. 2020;45:1–17.
Bijani A, Esmaili H, Ghadimi R, Babazadeh A, Rezaei R, Cumming RG, et al. Development and validation of a Semi-quantitative food frequency questionnaire among older people in north of Iran. Caspian J Int Med. 2018;9(1):78.
Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13(5):654–62.
Malmir H, Shayanfar M, Mohammad-Shirazi M, Tabibi H, Sharifi G, Esmaillzadeh A. Tea and coffee consumption in relation to glioma: a case-control study. Eur J Nutr. 2019;58(1):103–11.
Grioni S, Agnoli C, Sieri S, Pala V, Ricceri F, Masala G, et al. Espresso coffee consumption and risk of coronary heart disease in a large Italian cohort. PLoS ONE. 2015;10(5):e0126550.
Liu J, Sui X, Lavie CJ, Hebert JR, Earnest CP, Zhang J, et al., editors. Association of coffee consumption with all-cause and cardiovascular disease mortality. Mayo Clin Proc. 2013;88(10):1066–74.
Carlström M, Larsson SC. Coffee consumption and reduced risk of developing type 2 diabetes: a systematic review with meta-analysis. Nutr Rev. 2018;76(6):395–417.
Elhadad MA, Karavasiloglou N, Wulaningsih W, Tsilidis KK, Tzoulaki I, Patel CJ, et al. Metabolites, nutrients, and lifestyle factors in relation to coffee consumption: An Environment-Wide Association Study. Nutrients. 2020;12(5):1470.
Salazar-Martinez E, Willett WC, Ascherio A, Manson JE, Leitzmann MF, Stampfer MJ, et al. Coffee consumption and risk for type 2 diabetes mellitus. Ann Int Med. 2004;140(1):1–8.
Panagiotakos DB, Lionis C, Zeimbekis A, Makri K, Bountziouka V, Economou M, et al. Long-term, moderate coffee consumption is associated with lower prevalence of diabetes mellitus among elderly non-tea drinkers from the Mediterranean Islands (MEDIS Study). Rev Diabetic Stud: RDS. 2007;4(2):105.
van Dam RM, Hu FB, Willett WC. Coffee, caffeine, and health. N Engl J Med. 2020;383(4):369–78.
Kondo Y, Goto A, Noma H, Iso H, Hayashi K, Noda M. Effects of coffee and tea consumption on glucose metabolism: a systematic review and network meta-analysis. Nutrients. 2019;11(1):48.
Mirmiran P, Carlström M, Bahadoran Z, Azizi F. Long-term effects of coffee and caffeine intake on the risk of pre-diabetes and type 2 diabetes: findings from a population with low coffee consumption. Nutr Metab Cardiovasc Dis. 2018;28(12):1261–6.
Yarmolinsky J, Mueller NT, Duncan BB, Bisi Molina MdC, Goulart AC, Schmidt MI. Coffee consumption, newly diagnosed diabetes, and other alterations in glucose homeostasis: a cross-sectional analysis of the longitudinal study of adult health (ELSA-Brasil). PLoS One. 2015;10(5):e0126469.
Keirns B, Elliott D, Sciarrillo C, Koemel N, Poindexter K, Emerson S. Effect of Black Coffee on Fasting Metabolic Markers and an Abbreviated Fat Tolerance Test. Current Developments in Nutrition. 2020;4(Supplement_2):639-.
Borror A, Zieff G, Battaglini C, Stoner L. The effects of postprandial exercise on glucose control in individuals with type 2 diabetes: a systematic review. Sports Med. 2018;48(6):1479–91.
Palatini P, Benetti E, Mos L, Garavelli G, Mazzer A, Cozzio S, et al. Association of coffee consumption and CYP1A2 polymorphism with risk of impaired fasting glucose in hypertensive patients. Eur J Epidemiol. 2015;30(3):209–17.
Cornelis MC, Byrne EM, Esko T, Nalls MA, Ganna A, Paynter N, et al. Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption. Mol Psychiatry. 2015;20(5):647.
van Dam R. Can ‘omics’ studies provide evidence for causal effects of coffee consumption on risk of type 2 diabetes? J Intern Med. 2018;283(6):588–90.
Cano-Marquina A, Tarín J, Cano A. The impact of coffee on health. Maturitas. 2013;75(1):7–21.
Yen W-J, Wang B-S, Chang L-W, Duh P-D. Antioxidant properties of roasted coffee residues. J Agric Food Chem. 2005;53(7):2658–63.
Alhamhany NN, Alassady EH. Does green coffee has a positive effect on body mass index and lipid profile in a sample of obese people. J Pharm Sci Res. 2018;10(3):627–30.
Ihim A, Nwanua M, Ogbodo E, Meludu S. Effect of coffee consumption on blood glucose and lipid profile levels in male Students at Nnamdi Azikiwe University, Nnewi Campus, Anambra State. J Med Lab Sci. 2019;29(2):10–20.
Cai L, Ma D, Zhang Y, Liu Z, Wang P. The effect of coffee consumption on serum lipids: a meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2012;66(8):872–7.
Ranheim T, Halvorsen B. Coffee consumption and human health–beneficial or detrimental?–Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus. Mol Nutr Food Res. 2005;49(3):274–84.
Kim YT, Chung HJ, Park BR, Kim YY, Lee JH, Kang DR, et al. Risk of cardiovascular disease and chronic kidney disease according to 2017 blood pressure categories in diabetes mellitus. Hypertension. 2020;76(3):766–75.
Noordzij M, Uiterwaal CSPM, Arends LR, Kok FJ, Grobbee DE, Geleijnse JM. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens. 2005;23(5):921.
Mesas AE, Leon-Muñoz LM, Rodriguez-Artalejo F, Lopez-Garcia E. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr. 2011;94(4):1113–26.
Zhao Y, Wang J, Ballevre O, Luo H, Zhang W. Antihypertensive effects and mechanisms of chlorogenic acids. Hypertens Res. 2012;35(4):370–4.
Chrysant SG. The impact of coffee consumption on blood pressure, cardiovascular disease and diabetes mellitus. Expert Rev Cardiovasc Ther. 2017;15(3):151–6.
de Abreu Pinheiro F, Elias LF, de Jesus Filho M, Modolo MU, Rocha JdCG, Lemos MF, et al. Arabica and Conilon coffee flowers: Bioactive compounds and antioxidant capacity under different processes. Food chemistry. 2020;336:127701.